Patent 7108991 was granted and assigned to Arena Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office.
The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.